CENNA BIOSCIENCES INC

Developing Disease-Modifying Drugs for Alzheimer's Disease

SAN DIEGO, United States · Founded 2016 · $1.0M raised

Founded
2016
Business Model
B2G
Total Funding
$1.0M
Last Round
$1.0M GrantJan 2025

About

Cenna Biosciences is a privately-held biopharmaceutical company based in La Jolla, California, focused on developing novel disease-modifying treatments for Alzheimer's disease. Their lead drug candidate, Nubytide, is a proprietary peptide therapy that inhibits beta amyloid (Aß) production and reduces markers of inflammation and Tau pathology. Cenna has secured multiple NIH SBIR grants including a $2.7M Phase II award from the National Institute on Aging.

Summary

CENNA BIOSCIENCES INC is a Biotech company based in SAN DIEGO, United States, founded in 2016. It has raised $1.0M in total, most recently a $1.0M Grant round in Jan 2025.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Funding History

No funding data available yet.

Know something? Help us improve our data.

Similar Companies